Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11639325-43-1----[1] 254
25-probe cocktail----[1] 254
3A novel synthetic, orally-administered, non-peptide small molecule, which acts as----[1] 254
4AFAMELANOTIDE[1] Afamelanotide[1] D10511 [1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[2] 159, 254
5Afamelanotide Implant[1] Afamelanotide[1] D10511 [1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[1] 254
6ALN-60519----[1] 254
7ALN-AS1----[1] 254
8Aminolevulinic acid[1] Aminolevulinic acid[2] D02908 ,
D07567 		--[4] 34, 96, 254, 286
9CAS # in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----[1] 254
10CAS# in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----[1] 254
11Chlorpromazine[1] Chlorpromazine[4] D00270 ,
D00789 ,
D03274 ,
D04034 		[13] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2A,
HTR2B,
HTR2C 💬		[22] Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 254
12Chlorpromazine Hydrochloride[1] Chlorpromazine[4] D00270 ,
D00789 ,
D03274 ,
D04034 		[13] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2A,
HTR2B,
HTR2C 💬		[22] Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 254
13Cimetidine[1] Cimetidine[2] D00295 ,
D03503 		[1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[2] 2, 254
14Colestipol[1] Colestipol[2] D02113 ,
D07771 		--[1] 254
15COLESTYRAMINE[1] Cholestyramine---[1] 254
16Concentration unit: mg milligram(s)----[1] 254
17CUV1647----[1] 254
18Cysteine[1] Cysteine[2] D00026 ,
D02326 		--[11] 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310
19Cysteine hydrochloride[1] Cysteine[2] D00026 ,
D02326 		--[1] 254
20Deferasirox[1] Deferasirox[1] D03669 --[3] 254, 284, 286
21Dersimelagon----[2] 51, 254
22Exjade[1] Deferasirox[1] D03669 --[3] 254, 284, 286
23Givosiran[1] Givosiran[1] D11702 [1] ALAS1 💬[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
24Givosiran (ALN-AS1)[1] Givosiran[1] D11702 [1] ALAS1 💬[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
25Glucose[1] Dextrose, unspecified form---[15] 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299
26Harvoni[1] Sofosbuvir[1] D10366 --[1] 254
27Heme arginate----[1] 254
28Hemin[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
29Hemin for injection[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
30Hydroxychloroquine[1] Hydroxychloroquine[1] D08050 --[27] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
31Iron[1] Iron---[6] 18, 96, 97, 238, 254, 284
32Isoniazid[1] Isoniazid[3] D00346 ,
D01501 ,
D02002 		--[1] 254
33Luteinizing hormone[1] Luteinizing hormone---[1] 254
34Luteinizing hormone-releasing factor[1] Luteinizing hormone---[1] 254
35MT-7117----[2] 51, 254
36MT-7117 High Dose----[1] 254
37MT-7117 Low Dose----[1] 254
38Nle4,D-Phe7]-a-melanocyte stimulating hormone or NDP-a-MSH----[1] 254
39Nle4-D-Phe7-alpha-MSH----[1] 254
40Oral Iron[1] Iron---[2] 97, 254
41Other: Dosage of Delta-aminolevulinic acid and Porphobilinogen[2] Aminolevulinic acid,
Porphobilinogen		[2] D02908 ,
D07567 		--[1] 254
42Other: Glucose[1] Dextrose, unspecified form---[1] 254
43Panhematin[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
44Phlebotomy----[1] 254
45Porphobilinogen[1] Porphobilinogen---[1] 254
46Questran[1] Cholestyramine---[4] 93, 254, 297, 338
47Recombinant human porphobilinogen deaminase (Porphozym)[1] Porphobilinogen---[1] 254
48SCENESSE[1] Afamelanotide[1] D10511 [1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[3] 159, 161, 254
49Sterile Normal Saline (0.9% NaCl)----[3] 62, 234, 254
50Tin mesoporphyrin[1] Stannsoporfin[1] D05922 [2] HMOX1,
HMOX2 💬		[10] Chemical carcinogenesis - reactive oxygen species, Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin metabolism 💬[1] 254